N-acetylglutamate Synthase Deficiency
Oncology·MeSH: Glut1 Deficiency Syndrome
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target N-acetylglutamate Synthase Deficiency?
There are 1 clinical trial targeting N-acetylglutamate Synthase Deficiency tracked by BioSniper.
What is the prevalence of N-acetylglutamate Synthase Deficiency?
The estimated prevalence of N-acetylglutamate Synthase Deficiency is approximately 0.1 per 100,000 population.
Deep-dive into N-acetylglutamate Synthase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis